Literature DB >> 25867338

Genetic variations in microRNA genes and susceptibility to hepatocellular carcinoma.

D Li1, J J Peng1, Y Tan1, T Chen1, D Wei1, M Du1, T Zhang2.   

Abstract

We conducted a hospital-based case-control study to investigate the effect of the miR-146aG>C and miR-499A>G polymorphisms on the risk of hepatocellular carcinoma (HCC) in a Chinese population. This study was 1:1 matched case-control study consisting of 184 HCC patients and 184 control subjects. miR-146aG>C and miR-499A>G polymorphisms were genotyped by polymerase chain reaction-restriction fragment length polymorphism. Multivariate regression analyses showed that subjects carrying the miR-146a G allele and miR-499 G allele were associated with a non-significant increased risk of HCC compared with subjects with the homozygous allele, with adjusted odds ratios (95% confidence interval) of 1.38 (0.97-1.84) and 1.40 (0.99-2.08), respectively. Moreover, subjects carrying the miR-499 A allele showed a greatly increased risk of HCC in subjects infected with HBV compared with subjects carrying the miR-499 A allele, with an adjusted odds ratio (95% confidence interval) of 1.53 (1.34-2.41). In conclusion, the miR-146aG>C and miR-499A>G polymorphisms do not have a role in the genetic susceptibility to HCC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25867338     DOI: 10.4238/2015.March.20.2

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  8 in total

Review 1.  Association between miR-146a rs2910164 polymorphism and specific cancer susceptibility: an updated meta-analysis.

Authors:  Xia Hao; Lingzi Xia; Ruoyi Qu; Xianglin Yang; Min Jiang; Baosen Zhou
Journal:  Fam Cancer       Date:  2018-07       Impact factor: 2.375

2.  Association of miR-196a2 rs11614913 and miR-499 rs3746444 polymorphisms with cancer risk: a meta-analysis.

Authors:  Wanjun Yan; Xiaoyan Gao; Shuqun Zhang
Journal:  Oncotarget       Date:  2017-11-20

3.  A Meta-Analysis of miR-499 rs3746444 Polymorphism for Cancer Risk of Different Systems: Evidence From 65 Case-Control Studies.

Authors:  Xianglin Yang; Xuelian Li; Baosen Zhou
Journal:  Front Physiol       Date:  2018-06-12       Impact factor: 4.566

4.  Comprehensive assessment for miRNA polymorphisms in hepatocellular cancer risk: a systematic review and meta-analysis.

Authors:  Ben-Gang Wang; Li-Yue Jiang; Qian Xu
Journal:  Biosci Rep       Date:  2018-09-25       Impact factor: 3.840

5.  MiRNA Polymorphisms and Hepatocellular Carcinoma Susceptibility: A Systematic Review and Network Meta-Analysis.

Authors:  Qimeng Zhang; Xueying Xu; Mingcheng Wu; Tiantian Qin; Shaoning Wu; Hongbo Liu
Journal:  Front Oncol       Date:  2021-01-19       Impact factor: 6.244

6.  Effect of miR-196a2 rs11614913 Polymorphism on Cancer Susceptibility: Evidence From an Updated Meta-Analysis.

Authors:  Md Abdul Aziz; Tahmina Akter; Mohammad Safiqul Islam
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

Review 7.  MicroRNA-Related Polymorphisms in Infectious Diseases-Tiny Changes With a Huge Impact on Viral Infections and Potential Clinical Applications.

Authors:  Joel Henrique Ellwanger; Francis Maria Báo Zambra; Rafael Lima Guimarães; José Artur Bogo Chies
Journal:  Front Immunol       Date:  2018-06-14       Impact factor: 7.561

8.  Pathological changes of liver one year later in CHB patients with negative HBV DNA.

Authors:  Wu Shanshan; Du Xinfang; Yu Shuihong; Lai Kecong; Qi Jinjin; Chen Zhi; Chen Feng
Journal:  Infect Agent Cancer       Date:  2019-12-10       Impact factor: 2.965

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.